
    
      -  primary outcome Compare clinical efficacy of group treated with cell therapeutic
           Immuncell-LC evaluated by progression free survival with that of untreated group

        -  secondary outcome compare clinical efficacy of group treated with Immuncell-LC, a drug
           for treating advanced hepatocellular carcinoma evaluated by overall survival, disease
           control rate, changes of Alpha Feto Protein(AFP) figures from baseline to the last
           observation date and that of untreated group and evaluate adverse reactions, clinical
           pathological tests and its safety.
    
  